Literature DB >> 7893773

Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment.

P Dalgalarrondo1, W F Gattaz.   

Abstract

The purpose of the present study was to investigate CT abnormalities in tardive dyskinesia (TD) and to search for possible relationships with clinical data. A group of 30 psychotic patients (15 schizophrenic and 15 affective disorder) with TD was compared to a matched group of 30 psychiatric patients without TD and a matched group of 30 healthy controls. CT data were analyzed using two multivariate statistical methods [multidimensional scaling (MDS) and step-wise discriminant analysis]. MDS clearly separated both TD and non-TD groups from the healthy control group on the basis of CT parameters. Caudate left area reduction and left temporal sulci enlargement were the most important parameters that discriminated TD from non-TD patients. Only in TD-patients did caudate left area reduction and left temporal sulci enlargement correlate significantly with cumulative duration of psychiatric hospitalizations. The data of the present study support the findings of structural abnormalities in the caudate nucleus and in the temporal lobe of patients with TD. These abnormalities were especially marked in the left hemisphere. It is assumed that some factor related to longer psychiatric hospital treatment (e.g. neuroleptic intake) could account for these abnormalities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7893773     DOI: 10.1007/bf02190380

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  32 in total

1.  Laterality of torsion in tardive dystonia.

Authors:  P Sachdev
Journal:  Am J Psychiatry       Date:  1992-05       Impact factor: 18.112

Review 2.  Computed tomographic evaluation of patients with tardive dyskinesia.

Authors:  W F Hoffman; D E Casey
Journal:  Schizophr Res       Date:  1991 Jul-Aug       Impact factor: 4.939

3.  Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates.

Authors:  M P Caligiuri; H S Bracha; J B Lohr
Journal:  Psychiatry Res       Date:  1989-12       Impact factor: 3.222

4.  Depression as a risk factor in tardive dyskinesia.

Authors:  M Rush; F Diamond; M Alpert
Journal:  Biol Psychiatry       Date:  1982-03       Impact factor: 13.382

5.  Lateral asymmetries of tardive dyskinesia in schizophrenia.

Authors:  L L Altshuler; J L Cummings; G Bartzokis; M A Hill; P R May
Journal:  Biol Psychiatry       Date:  1988-05       Impact factor: 13.382

6.  Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging.

Authors:  S Raz; N Raz
Journal:  Psychol Bull       Date:  1990-07       Impact factor: 17.737

7.  Gender differences in tardive dyskinesia: a critical review of the literature.

Authors:  R Yassa; D V Jeste
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

8.  Persistent tardive dyskinesia: demographic and pharmacological risk factors.

Authors:  G Muscettola; S Pampallona; G Barbato; M Casiello; P Bollini
Journal:  Acta Psychiatr Scand       Date:  1993-01       Impact factor: 6.392

9.  CT scans and neuroleptic response in schizophrenia: a multidimensional approach.

Authors:  W F Gattaz; W Rost; K Kohlmeyer; K Bauer; C Hübner; T Gasser
Journal:  Psychiatry Res       Date:  1988-12       Impact factor: 3.222

10.  Lateralization of neuroleptic-induced dyskinesia indicates pharmacologic asymmetry in the brain.

Authors:  R Waziri
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  6 in total

Review 1.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.

Authors:  C Konradi; S Heckers
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

Review 2.  Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.

Authors:  Vladimir Lerner; Chanoch Miodownik
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

Review 3.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.

Authors:  B U Khan
Journal:  J Autism Dev Disord       Date:  1997-08

5.  Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients.

Authors:  Victor Peralta; Manuel J Cuesta; Jose F Serrano
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

6.  Psychiatric neuroimaging research in Brazil: historical overview, current challenges, and future opportunities.

Authors:  Geraldo Busatto Filho; Pedro G Rosa; Mauricio H Serpa; Paula Squarzoni; Fabio L Duran
Journal:  Braz J Psychiatry       Date:  2020-06-08       Impact factor: 2.697

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.